ProACT for Treatment of Male SUI

Chapter

Abstract

Several groups worldwide have included ProACT implantation in their armamentarium to treat male incontinence. The success rate varies from 56 to 92%. However, it is important to note that EBRT is a contraindication for ProACT implantation and that transurethral manipulations or urethral fibrosis may cause less favorable outcomes. The reoperation rate is significant, but the character of complications (balloon rupture, migration, port infection) is mild. The minimal invasivity and good results when well indicated have led to a constant use of this product over more than a decade, while many other products have been introduced, but soon after left the market.

References

  1. 1.
    Hübner WA, Schlarp OM. Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. BJU Int. 2005;96:587–94.CrossRefPubMedGoogle Scholar
  2. 2.
    Gregori A, Simonato A, Lissiani A, Scieri F, Rossi R, Gaboardi F. Transrectal ultrasound guided implantation of the ProACT adjustable continence therapy system in patients with post-radical prostatectomy stress urinary incontinence: a pilot study. J Urol. 2006;176(51):2109–13.CrossRefPubMedGoogle Scholar
  3. 3.
    Gregori A, Romano AL, Scieri F, Pietroantuono F, Incarbone GP, Salvaggio A, Granata A, Gaboardi F. Transrectal ultrasound-guided implantation of adjustable continence therapy (ProACT): surgical technique and clinical results after a mean follow-up of 2 years. Euro Urol. 2010;57(3):430–6.CrossRefGoogle Scholar
  4. 4.
    Crivellaro S, Singla A, Aggarwal N, Frea B, Kocjancic E. Adjustable continence therapy (ProACT) and bone anchored male slings: comparison of two new treatments of post prostatectomy incontinence. Int J Urol. 2008;15(10):910–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Gilling PJ, Bell DF, Wilson LC, Westenberg AM, Reuther R, Fraun-dorfer MR. An adjustable continence therapy device for treating incontinence after prostatectomy: a minimum 2-year follow-up. BJU Int. 2008;102:1426–30.PubMedGoogle Scholar
  6. 6.
    Trigo-Rocha F, Mendes Gomes C, Lima Pompeo AC, Marmo Lucon A, Arap S. Prospective study evaluating efficacy and safety of adjustable continence therapy (ProACT) for post radical prostatectomy urinary incontinence. Urology. 2005;67(5):965–9.CrossRefGoogle Scholar
  7. 7.
    Hübner WA, Schlarp OM. Adjustable continence therapy (ProACT): evolution of the surgical technique and comparison of the original 50 patients with the most recent 50 patients at a single centre. Euro Assoc Urol. 2006;52(3):680–6.CrossRefGoogle Scholar
  8. 8.
    Kocjancic E, Crivellaro S, Ranzoni S, Bonvini D, Gontero P, Frea B. Adjustable continence therapy for the treatment of male stress urinary incontinence: a single-centre study. Scand J Urol Nephrol. 2007;41:324–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Martens FM, Lampe MI, Heesakkers JP. ProACT for stress urinary incontinence after radical prostatectomy. Urol Int. 2009;82(4):394–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Garcia Matres MJ, Cansino Alcaide JR, Monasterio S, Rodriguez de Bethencourt F, Hidalgo Togores L, de la Pena Barthel J. Paraurethral adjustable continence therapy device (Pro-ACT) in the treatment of urinary incontinence after prostatic surgery. Arch Esp Urol. 2009;62(10):871–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Bretterbauer KM, Huber ER, Remzi M, Huebnr WA. Telephone - delivered quality of life after 365 male stress urinary incontinence (SUI) operations. Int Braz J Urol. 2016;42(5):986–92.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of UrologyKorneuburg Hospital and Karl Landsteiner Institute for Functional Disorders and Disorders Tumors of the Urinary TractKorneuburgAustria

Personalised recommendations